| Phase 4 |
| NCT05493267 |
A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB |
MDR-TB |
Recruiting |
| NCT07754812 |
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment… |
NSCLC (Non-small Cell Lung Cancer) |
Recruiting |
| NCT07141810 |
Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic… |
Fibrotic Interstitial Lung Disease |
Not Yet Recruiting |
| NCT07393386 |
Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally… |
Pain Management |
Not Yet Recruiting |
| NCT07469488 |
A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM)… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Not Yet Recruiting |
| Phase 3 |
| NCT04772287 |
Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2)… |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT05496166 |
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and… |
Limited Stage Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT07169903 |
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A… |
Lung Adenocarcinoma |
Not Yet Recruiting |
| NCT07608159 |
Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
| Phase 2 |
| NCT03351842 |
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% |
Chemotherapy, Adjuvant |
Recruiting |
| NCT05053802 |
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients… |
Multiple Primary Lung Cancer |
Recruiting |
| NCT05503667 |
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable… |
Lung Adenocarcinoma Stage III |
Recruiting |
| NCT04539977 |
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage… |
Small-cell Lung Cancer |
Recruiting |
| NCT04728724 |
Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer |
Non-small Cell Lung Cancer Stage III |
Recruiting |
| NCT06256237 |
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum… |
Limited Stage Small Cell Lung Cancer |
Recruiting |
| NCT06528847 |
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT05766800 |
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy… |
Locally Advanced |
Recruiting |
| NCT06749860 |
Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical… |
Lung Cancer |
Recruiting |
| NCT06749886 |
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in… |
Lung Cancer |
Recruiting |
| NCT06987734 |
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With… |
Lung Cancer (NSCLC) |
Recruiting |
| NCT06758700 |
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung… |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Recruiting |
| NCT07323056 |
Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ… |
EGFR-mutant Non-small Cell Lung Cancer |
Recruiting |
| NCT07408635 |
IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in… |
Unresectable Stage III Non-small Cell Lung Cancer |
Recruiting |
| NCT07410975 |
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant… |
NSCLC Stage II |
Recruiting |
| NCT06019468 |
Neoadjuvant Treatment For Locally Advanced Thymic Cancer |
Thymic Carcinoma |
Recruiting |